Vanguard Group
EDVA

Vanguard Group’s Endovia Health Sciences, Inc. EDVA Stock Holding History

Vanguard Group’s Portfolio EDVA Stock Details EDVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$7.65K Sell
2,772
-1,245
-31% -$7.46K ﹤0.01% 4324
2025
Q3 		$37.9K Hold
4,017
– – ﹤0.01% 4316
2025
Q2 		$60.4K Sell
4,017
-2,563
-39% -$42K ﹤0.01% 4184
2025
Q1 		$36.8K Sell
6,580
-1,282
-16% -$36K ﹤0.01% 4215
2024
Q4 		$203K Hold
7,862
– – ﹤0.01% 4101
2024
Q3 		$317K Hold
7,862
– – ﹤0.01% 4068
2024
Q2 		$289K Hold
7,862
– – ﹤0.01% 4107
2024
Q1 		$579K Hold
7,862
– – ﹤0.01% 3977
2023
Q4 		$695K Hold
7,862
– – ﹤0.01% 3937
2023
Q3 		$742K Hold
7,862
– – ﹤0.01% 3936
2023
Q2 		$1.41M Hold
7,862
– – ﹤0.01% 3788
2023
Q1 		$2.06M Hold
7,862
– – ﹤0.01% 3661
2022
Q4 		$1.21M Buy
7,862
+766
+11% +$134K ﹤0.01% 3848
2022
Q3 		$1.55M Sell
7,096
-1,049
-13% -$398K ﹤0.01% 3850
2022
Q2 		$3.9M Sell
8,145
-859
-10% -$310K ﹤0.01% 3511
2022
Q1 		$4.09M Buy
9,004
+8,915
+10,017% +$4.55M ﹤0.01% 3626
2021
Q4 		$17K Hold
89
– – ﹤0.01% 4634
2021
Q3 		$29K Buy
+89
New +$40.2K ﹤0.01% 4545

Other funds holding EDVA

LWM
Lifetime Wealth Management Rockwall, Texas $171M AUM
CL
Choreo LLC Rockford, Illinois $9.11B AUM 26.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group's EDVA Position: Q4 2025 in Review

Vanguard Group reduced its Endovia Health Sciences, Inc. (EDVA) stake by 31% in Q4 2025, selling an estimated $7.46K and leaving 2,772 shares worth $7.65K. The position accounts for ﹤0.01% of the portfolio, ranked #4324.

Vanguard Group first reported a position in EDVA in Q3 2021 and has held it in 18 quarters since. The position peaked at $4.09M in Q1 2022. 13 funds tracked by Wall St. Rank hold EDVA as of Q4 2025.

  • Vanguard Group held 2,772 shares of Endovia Health Sciences, Inc. worth $7.65K as of Q4 2025.
  • Vanguard Group sold 1,245 Endovia Health Sciences, Inc. shares in Q4 2025, an estimated $7.46K.
  • Endovia Health Sciences, Inc. made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #4324 holding.
  • Vanguard Group first reported a position in Endovia Health Sciences, Inc. in Q3 2021 and has held it in 18 quarters since.
  • Vanguard Group's Endovia Health Sciences, Inc. position peaked at $4.09M in Q1 2022.
  • 13 funds tracked by Wall St. Rank held Endovia Health Sciences, Inc. as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.